PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity

Table 8 Total 2013/14 expenditure by modelled disease (£000 s except cost per prevalent case) Reproduction of Tables 2, 3, 4 and 5 in Briggs et al. (with permission) [85]

Modelled disease	Programme budgeting category	Programme budgeting expenditure	Specialised services expenditure	Primary care expenditure	Total NHS England disease costs	Annual cost per prevalent case (£)
Modelled disease	Programme budgeting category	Step 1	Step 2	Step 3	Total NHS England disease costs	Annual cost per prevalent case (£)
Ischaemic heart disease	10a Coronary Heart Disease	953,743	41,818	485,056	1,480,617	1905
Stroke	10b Cerebrovascular disease	689,876	55,443	29,475	774,794	843
Type two diabetes	04a Diabetes	1,071,537	25,577	959,716	2,056,831	444
Breast cancer	02f Cancer, breast	472,192^a	N/A	N/A	472,192	573
Colon cancer	02c Cancer, lower GI	248,315	84,919	20	333,253	810
Lung cancer	02d Cancer, lung	98,250	33,599	0^b	131,849	904
Stomach cancer	02b Cancer, upper GI	32,794	11,215	0^b	44,008	535
Liver cancer	02b Cancer, upper GI	16,990	5810	0^b	22,801	1532
Kidney cancer	02 h Cancer, urological	25,145	8599	7833	41,577	618
Pancreatic cancer	02b Cancer, upper GI	42,133	14,409	0^b	56,542	3074
Liver disease	13c Hepatobiliary	59,702	4543	2963	67,209	314

^aBreast cancer costs are not estimated from programme budgeting expenditure but directly from Luengo-Fernandez et al [86]. GI gastrointestinal, N/A not applicable; ^bprimary care costs estimated to be negligible

ISSN: 1472-6963